12/07/2024  17:11:27 Var. - Volume Denaro17:30:00 Lettera17:30:00 Capitalizzazione di mercato Dividend Y. Rapporto P/E
11.14EUR - 426
Fatturato: 4,751.70
-Quantità in denaro: - -Quantità in lettera: - 2.54 bill.EUR - 27.48

Descrizione business

SYNLAB Group is the largest European clinical laboratory and medical diagnostic services provider by revenue and number of tests. SYNLAB offers a full range of innovative and reliable medical diagnostics for patients, practising doctors, clinics and the pharmaceutical industry. Providing the leading level of service within the industry, SYNLAB is the partner of choice for diagnostics in human and veterinary medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Mathieu Floreani
Consiglio di amministrazione
Sami Badarani, Robert Steinwander, Dr Santiago Valor, Luis Vieira, Henrik Andreasen, Catharina Monster, Dr Fabian Walla
Consiglio di sorveglianza
Prof Dr David Ebsworth, Barbara Lambert, Dr Bartl Wimmer, Alex Leslie, Anastasya Molodykh-McFarlane, Christian Salling, Karin Bierstedt, Dr Stefan Graf, Dr Ute Hasholzner, Rene Schmidt-Ferroud, Marc Welters, Iris Schopper
 

Dati aziendali

Name: SYNLAB AG
Indirizzo: Moosacher Straße 88,D-80809 München
Telefono: +49-89-307-602-0
Fax: -
E-mail: info@synlab.com
Internet: https://www.synlab.de/
Industria: Healthcare
Settore: Healthcare Providers
Sub settore: Healthcare Providers
Fine dell'anno finanziario: 31/12
Flottante libero: -
Data dell'IPO: -

Rapporti con gli investitori

Name: -
IR telefono: +49 89 307602-0
IR Fax: -
IR e-mail: ir@synlab.com

Principali azionisti

Cinven
 
43.00%
FreeFloat
 
19.00%
Novo
 
19.00%
OTPP
 
9.00%
QIA
 
5.00%
Elliott
 
5.00%